Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) – protocol for a multi-center, single-arm phase IIa trial

Introduction: Sarcoidosis is a granulomatous systemic disease that becomes chronic in approximately one third of affected patients resulting in quality of life and functional impairment. Immunosuppressive drugs other than steroids represent alternative therapeutic options, but side effects like live...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Björn C. Frye, Ina Caroline Rump, Annette Uhlmann, Fabian Schubach, Gabriele Ihorst, Bodo Grimbacher, Gernot Zissel, Joachim Müller Quernheim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2020-09-01
coleção:	Contemporary Clinical Trials Communications
Assuntos:	Chronic sarcoidosis Therapy Abatacept Regulatory T-cells Patient-reported outcome King's sarcoidosis questionnaire
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2451865420300594
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!